, Tracking Stock Market Picks
Enter Symbol:
Intuitive Surgical, Inc. (ISRG) [hlAlert]

up 56.98 %

Intuitive Surgical, Inc. (ISRG) rated Buy with price target $475 by Collins Stewart

Posted on: Wednesday,  Oct 19, 2011  8:25 AM ET by Collins Stewart

Collins Stewart rated Buy Intuitive Surgical, Inc. (NASDAQ: ISRG) on 10/19/2011. Previously Collins Stewart rated Buy Intuitive Surgical, Inc. (NASDAQ: ISRG) on
03/10/2011., when the stock price was $328.41. Since then, Intuitive Surgical, Inc. has gained 56.99% as of 01/22/2016's recent price of $515.57.
If you would have followed the previous Collins Stewart's recommendation on ISRG, you would have gained 56.98% of your investment in 1779 days.

Intuitive Surgical, Inc. designs and manufactures the da Vinci Surgical System. The da Vinci Surgical System seamlessly translates the surgeon's natural hand movements on instrument controls at a console into corresponding micromovements of instruments positioned inside the patient through small puncture incisions, or ports. The products provide the surgeon with the range of motion and fine tissue control previously possible only with open surgery, while simultaneously allowing the surgeon to work through small ports.

Collins Stewart's research department is built around a number of sector-specialist teams. Our analysts are leaders in their area of specialisation and combine deep industry knowledge with decades of stock broking experience to produce insightful, independent sector research. Our research approach encompasses Questâ„¢ principles and focuses on cash-driven valuation techniques. Research is a Collins Stewart cornerstone; it is leveraged throughout the organisation.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/19/2011 8:25 AM Buy
414.97 475.00
as of 12/30/2011
1 Week up  1.16 %
1 Month up  6.63 %
3 Months up  27.10 %
1 YTD up  11.57 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/10/2011 8:25 AM Buy
328.41 400.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy